BASEL (dpa-AFX) - Novartis (NVS) announced that Entresto
(sacubitril/valsartan) has been given a Class
I recommendation in updated clinical practice guidelines simultaneously released
by the American College of Cardiology (ACC), the American Heart...
Novartis AG (ADR) (NYSE: NVS) announced on Thursday the establishment of FortiHFy, short for Fortifying Heart Failure clinical evidence and patient quality of life.
FortiHFy is an umbrella clinical program that consists of over 40 active or...
BASEL (dpa-AFX) - Novartis (NVS) said it will highlight the strength of its
oncology research programs at the upcoming 52nd Annual Meeting of the American
Society of Clinical Oncology (ASCO), being held June 3-7 in Chicago. Data will
Novartis to present pivotal data in hematologic and solid tumor cancers at
2016 ASCO Annual Meeting
Novartis International AG /
Novartis to present pivotal data in hematologic and solid tumor cancers at 2016
ASCO Annual Meeting
. Processed and...
BRUSSELS (dpa-AFX) - The Swiss stock market ended Wednesday's session with a
significant increase. The market got off to a weak start, before staging a
recovery and slipped back into the red in the afternoon. The market bounced back